These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11560059)

  • 21. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designing transcription factor architectures for drug discovery.
    Blancafort P; Segal DJ; Barbas CF
    Mol Pharmacol; 2004 Dec; 66(6):1361-71. PubMed ID: 15340042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computer-aided design of a PDZ domain to recognize new target sequences.
    Reina J; Lacroix E; Hobson SD; Fernandez-Ballester G; Rybin V; Schwab MS; Serrano L; Gonzalez C
    Nat Struct Biol; 2002 Aug; 9(8):621-7. PubMed ID: 12080331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting metal-binding site residues in low-resolution structural models.
    Sodhi JS; Bryson K; McGuffin LJ; Ward JJ; Wernisch L; Jones DT
    J Mol Biol; 2004 Sep; 342(1):307-20. PubMed ID: 15313626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting protein druggability.
    Hajduk PJ; Huth JR; Tse C
    Drug Discov Today; 2005 Dec; 10(23-24):1675-82. PubMed ID: 16376828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macromolecular therapeutics: emerging strategies for drug discovery in the postgenome era.
    Juliano RL; Astriab-Fisher A; Falke D
    Mol Interv; 2001 Apr; 1(1):40-53. PubMed ID: 14993337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-residue interactions in protein folding and stability.
    Gromiha MM; Selvaraj S
    Prog Biophys Mol Biol; 2004 Oct; 86(2):235-77. PubMed ID: 15288760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure based design of functional metal/protein hybrids.
    Ueno T; Yokoi N; Abe S; Watanabe Y
    J Inorg Biochem; 2007 Nov; 101(11-12):1667-75. PubMed ID: 17675160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinatorial docking approach for structure prediction of large proteins and multi-molecular assemblies.
    Inbar Y; Benyamini H; Nussinov R; Wolfson HJ
    Phys Biol; 2005 Nov; 2(4):S156-65. PubMed ID: 16280621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational design of proteins stereochemically optimized in size, stability, and folding speed.
    Joshi S; Rana S; Wangikar P; Durani S
    Biopolymers; 2006 Oct; 83(2):122-34. PubMed ID: 16683262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein structure prediction based on sequence similarity.
    Jaroszewski L
    Methods Mol Biol; 2009; 569():129-56. PubMed ID: 19623489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein structure prediction of CASP5 comparative modeling and fold recognition targets using consensus alignment approach and 3D assessment.
    Ginalski K; Rychlewski L
    Proteins; 2003; 53 Suppl 6():410-7. PubMed ID: 14579329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.
    Esteras-Chopo A; Morra G; Moroni E; Serrano L; Lopez de la Paz M; Colombo G
    J Mol Biol; 2008 Oct; 383(1):266-80. PubMed ID: 18703072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent applications of protein crystallography and structure-guided drug design.
    Williams SP; Kuyper LF; Pearce KH
    Curr Opin Chem Biol; 2005 Aug; 9(4):371-80. PubMed ID: 16006182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence and structural analysis of cellular retinoic acid-binding proteins reveals a network of conserved hydrophobic interactions.
    Gunasekaran K; Hagler AT; Gierasch LM
    Proteins; 2004 Feb; 54(2):179-94. PubMed ID: 14696180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochromes P450 and drug discovery.
    Lamb DC; Waterman MR; Kelly SL; Guengerich FP
    Curr Opin Biotechnol; 2007 Dec; 18(6):504-12. PubMed ID: 18006294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-hairpin peptidomimetics: design, structures and biological activities.
    Robinson JA
    Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of protein domains on topological basis.
    Anselmi C; Bocchinfuso G; Scipioni A; De Santis P
    Biopolymers; 2001 Feb; 58(2):218-29. PubMed ID: 11093120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.